BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27368419)

  • 1. Stabilization of C-RAF:KSR1 complex by DiRas3 reduces availability of C-RAF for dimerization with B-RAF.
    Baljuls A; Dobrzyński M; Rauch J; Rauch N; Kolch W
    Cell Signal; 2016 Oct; 28(10):1451-62. PubMed ID: 27368419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor DiRas3 forms a complex with H-Ras and C-RAF proteins and regulates localization, dimerization, and kinase activity of C-RAF.
    Baljuls A; Beck M; Oenel A; Robubi A; Kroschewski R; Hekman M; Rudel T; Rapp UR
    J Biol Chem; 2012 Jun; 287(27):23128-40. PubMed ID: 22605333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.
    Klingauf M; Beck M; Berge U; Turgay Y; Heinzer S; Horvath P; Kroschewski R
    Biol Cell; 2013 Feb; 105(2):91-107. PubMed ID: 23157514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEK drives BRAF activation through allosteric control of KSR proteins.
    Lavoie H; Sahmi M; Maisonneuve P; Marullo SA; Thevakumaran N; Jin T; Kurinov I; Sicheri F; Therrien M
    Nature; 2018 Feb; 554(7693):549-553. PubMed ID: 29433126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAF inhibitor-induced KSR1/B-RAF binding and its effects on ERK cascade signaling.
    McKay MM; Ritt DA; Morrison DK
    Curr Biol; 2011 Apr; 21(7):563-8. PubMed ID: 21458265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CK2 Is a component of the KSR1 scaffold complex that contributes to Raf kinase activation.
    Ritt DA; Zhou M; Conrads TP; Veenstra TD; Copeland TD; Morrison DK
    Curr Biol; 2007 Jan; 17(2):179-84. PubMed ID: 17174095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters.
    Sutton MN; Lu Z; Li YC; Zhou Y; Huang T; Reger AS; Hurwitz AM; Palzkill T; Logsdon C; Liang X; Gray JW; Nan X; Hancock J; Wahl GM; Bast RC
    Cell Rep; 2019 Dec; 29(11):3448-3459.e6. PubMed ID: 31825828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites.
    Ory S; Zhou M; Conrads TP; Veenstra TD; Morrison DK
    Curr Biol; 2003 Aug; 13(16):1356-64. PubMed ID: 12932319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR).
    Zhou M; Horita DA; Waugh DS; Byrd RA; Morrison DK
    J Mol Biol; 2002 Jan; 315(3):435-46. PubMed ID: 11786023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dimerization-dependent mechanism drives RAF catalytic activation.
    Rajakulendran T; Sahmi M; Lefrançois M; Sicheri F; Therrien M
    Nature; 2009 Sep; 461(7263):542-5. PubMed ID: 19727074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Binding Preferences between Ras and Raf Family Members and the Impact on Oncogenic Ras Signaling.
    Terrell EM; Durrant DE; Ritt DA; Sealover NE; Sheffels E; Spencer-Smith R; Esposito D; Zhou Y; Hancock JF; Kortum RL; Morrison DK
    Mol Cell; 2019 Dec; 76(6):872-884.e5. PubMed ID: 31606273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF.
    Hu J; Yu H; Kornev AP; Zhao J; Filbert EL; Taylor SS; Shaw AS
    Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6067-72. PubMed ID: 21441104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and role of Raf-1/B-Raf heterodimerization.
    Rushworth LK; Hindley AD; O'Neill E; Kolch W
    Mol Cell Biol; 2006 Mar; 26(6):2262-72. PubMed ID: 16508002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling threshold regulation by the Ras effector IMP.
    Matheny SA; White MA
    J Biol Chem; 2009 Apr; 284(17):11007-11. PubMed ID: 19091743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling dynamics of the KSR1 scaffold complex.
    McKay MM; Ritt DA; Morrison DK
    Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11022-7. PubMed ID: 19541618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.
    Garnett MJ; Rana S; Paterson H; Barford D; Marais R
    Mol Cell; 2005 Dec; 20(6):963-9. PubMed ID: 16364920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).
    Karreth FA; DeNicola GM; Winter SP; Tuveson DA
    Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
    Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
    Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice.
    Lozano J; Xing R; Cai Z; Jensen HL; Trempus C; Mark W; Cannon R; Kolesnick R
    Cancer Res; 2003 Jul; 63(14):4232-8. PubMed ID: 12874031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation.
    Razidlo GL; Kortum RL; Haferbier JL; Lewis RE
    J Biol Chem; 2004 Nov; 279(46):47808-14. PubMed ID: 15371409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.